Vildagluse 50 Mg 30 Tablets

Vildagluse 50 Mg 30 Tablets

Description:

Vildagluse 50 mg 30 tablets is an oral anti-diabetic prescription medicine containing vildagliptin, a dipeptidyl peptidase-4 (dpp-4) inhibitor. It is used as part of a comprehensive diabetes care plan to help control blood glucose levels in adults with type 2 diabetes mellitus, usually in combination with diet and exercise and sometimes with other anti-diabetic medicines. By enhancing the body’s own incretin system, Vildagluse helps improve insulin secretion after meals and reduces glucose production by the liver, supporting more stable blood sugar control throughout the day.

Indications:

• Management of type 2 diabetes mellitus in adults, as monotherapy when metformin is not suitable or contraindicated (e.g. intolerance or renal impairment), as directed by a physician.
• Adjunctive therapy to other oral anti-diabetic agents (such as metformin, sulfonylureas, thiazolidinediones, or insulin) in adults with type 2 diabetes mellitus who do not achieve adequate glycemic control with these medicines alone.
• Helps reduce elevated fasting and postprandial (after-meal) blood glucose levels.
• Supports improvement in overall glycemic control parameters such as fasting plasma glucose and hba1c, when used as prescribed.

Active Ingredients / Key Components:

• Vildagliptin – 50 mg per tablet.
• Other inactive ingredients/excipients: Not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.). Please refer to the enclosed patient leaflet or outer pack for the full list of excipients.

Dosage & Administration / How to Use:

• The exact dose and regimen must always be determined by the treating physician based on individual patient needs, kidney function, and concomitant medications.
• Typical adult dosing for vildagliptin-containing products in type 2 diabetes is often 50 mg once or twice daily, depending on whether it is used alone or in combination with other anti-diabetic medicines. However, you must follow your doctor’s specific instructions for Vildagluse 50 mg.
• Swallow the tablet whole with a glass of water. Do not crush or chew unless your doctor or pharmacist advises otherwise.
• Can usually be taken with or without food; taking it at the same time(s) each day helps maintain consistent blood levels and improves adherence.
• If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not take a double dose to make up for a missed one.
• Use Vildagluse as part of a complete diabetes management plan including diet, exercise, weight control, and regular blood glucose monitoring.

Clinical Benefits:

• Helps improve glycemic control in adults with type 2 diabetes mellitus by enhancing glucose-dependent insulin secretion and reducing inappropriate glucagon release.
• Reduces both fasting and post-meal blood glucose levels, contributing to improved hba1c values when used regularly as prescribed.
• Low intrinsic risk of hypoglycemia when used alone (monotherapy) because its action is glucose-dependent; however, the risk may increase when combined with sulfonylureas or insulin.
• Generally weight-neutral, making it suitable for patients where weight gain is undesirable as part of diabetes management.

Warnings & Contraindications:

• Use only under medical supervision. This is a prescription medicine for type 2 diabetes and is not suitable for type 1 diabetes or for the treatment of diabetic ketoacidosis.
• Contraindicated in patients with known hypersensitivity or allergy to vildagliptin or any of the excipients in the formulation.
• Use with caution in patients with moderate to severe renal impairment or hepatic impairment. Liver function tests may be recommended periodically by your doctor.
• Cases of liver dysfunction, including hepatitis, have been reported with vildagliptin. Discontinue and contact your doctor if you develop symptoms such as persistent nausea, vomiting, abdominal pain, fatigue, dark urine, or jaundice (yellowing of skin or eyes).
• Pancreatitis has been reported with dpp-4 inhibitors. Seek urgent medical attention if you experience severe, persistent abdominal pain (with or without vomiting).
• Hypoglycemia risk increases when Vildagluse is used in combination with sulfonylureas or insulin. Your doctor may adjust doses of the other medicines to reduce this risk.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. The safety of vildagliptin in pregnancy and lactation is not well established; alternative treatments may be preferred.
• Inform your doctor about all other medicines you are taking, including other anti-diabetic drugs, cardiovascular medications, and over-the-counter or herbal products, to avoid potential interactions.
• Not intended for use in children and adolescents unless specifically prescribed by a specialist.
• Consult your doctor before use if you have medical conditions such as heart failure, liver disease, kidney disease, pancreatitis, or a history of serious gastrointestinal disorders.
• Do not share this medication with others, even if they have similar symptoms or conditions.
• Keep out of reach of children.

Side Effects:

• Common side effects may include headache, dizziness, mild gastrointestinal disturbances (such as nausea, constipation, or diarrhea), and upper respiratory tract infections (such as sore throat or runny nose).
• Less common side effects can include fatigue, peripheral edema (swelling of hands or feet), or mild skin reactions such as rash or itching.
• Serious but rare side effects may include pancreatitis (severe abdominal pain, often radiating to the back), liver dysfunction (jaundice, dark urine, persistent nausea or fatigue), or severe allergic reactions (swelling of face, lips, tongue, or throat; difficulty breathing; severe rash). Seek immediate medical attention if these occur.
• If you experience signs of hypoglycemia (sweating, tremor, palpitations, hunger, confusion, blurred vision) especially when Vildagluse is taken with sulfonylureas or insulin, check your blood glucose and follow your doctor’s advice for treating low blood sugar.
• Report any unexpected, persistent, or bothersome side effects to your doctor or pharmacist for assessment and possible adjustment of therapy.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Do not store above the temperature specified on the outer packaging (if provided). Dispose of unused or expired tablets according to pharmacist or local regulations; do not throw into household waste or wastewater.

Specifications:

• Product type: Prescription anti-diabetic medicine (dpp-4 inhibitor).
• Strength: 50 mg vildagliptin per tablet.
• Form: Tablet.
• Pack size: 30 tablets per pack.
• Intended users: Adults with type 2 diabetes mellitus, as prescribed by a physician.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.